GlassScriptPhysician profile
Robert J Fauer
NPI 1114988672
$1,572.20
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,180 · 2020: $392.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $324.23 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $193.81 | 2019-2020 | |
| Watermark Medical, INC. | $155.00 | 2020 | |
| Janssen Pharmaceuticals, INC | $131.00 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $94.91 | 2019-2020 | |
| Novo Nordisk INC | $68.18 | 2019-2020 | |
| Pfizer INC. | $67.64 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $64.11 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $58.10 | 2019 | |
| Lilly USA, LLC | $48.90 | 2019-2020 | |
| Stryker Corporation | $47.52 | 2019 | |
| Astellas Pharma US INC | $44.51 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $38.84 | 2019 | |
| Abbott Laboratories | $36.98 | 2019 | |
| Medtronic USA, INC. | $29.80 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $24.72 | 2019 | |
| Amgen INC. | $21.72 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $16.85 | 2019 | |
| Boston Scientific Corporation | $16.45 | 2020 | |
| Bausch Health US, LLC | $16.43 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.98 | 2019 | |
| Sanofi Pasteur INC. | $15.14 | 2019 | |
| Amarin Pharma, INC. | $14.30 | 2019 | |
| Allergan, INC. | $13.56 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $13.52 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Fauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.